Argireline (CAS 616204-22-9) – Purity 99.43% | GMP Factory

描述

Argireline, also known as Acetyl Hexapeptide-8, is a synthetic peptide that mimics the N-terminal end of SNAP-25, a substrate of the SNARE complex involved in neurotransmitter release. By inhibiting SNARE complex formation, Argireline reduces the release of neurotransmitters that cause muscle contraction, thereby relaxing facial muscles and reducing the appearance of wrinkles.

This peptide is widely researched in cosmetic science as a non-invasive alternative to botulinum toxin for anti-aging treatments. Argireline’s effects include muscle relaxation, wrinkle reduction, and improved skin appearance.

Manufactured under GMP conditions with a purity of 99.43%, this product supports reliable research in dermatology and cosmetic formulation studies.

Product Specifications

Mechanism of Action & Research Applications

Argireline acts by blocking the formation of the SNARE complex, preventing neurotransmitter release at neuromuscular junctions. This mechanism reduces muscle contraction, making it valuable in research focused on wrinkle reduction and muscle relaxation therapies.

It is widely used in the development of cosmetic products aimed at anti-aging and skin rejuvenation. Additionally, Argireline is studied for its effects on facial muscle modulation and neuropeptide interactions in skin.

Side Effects (For Research Reference Only)

In research settings, Argireline may cause mild skin irritation or allergic reactions in sensitive models. It does not carry the systemic side effects associated with injectable muscle relaxants.

Disclaimer

Argireline is intended exclusively for laboratory research purposes. It is not approved for human consumption, diagnostic, or therapeutic use. Handle with appropriate safety measures.